The company will broadcast a live webcast of its earnings conference call starting at 8 a.m. Central time. Shareholders and analysts can access the session through the investor relations portal at investors.abbvie.com. For those unable to attend the live presentation, an archived version of the call will be published on the same website later that day.
In section Releases
AbbVie Sets July 31 Date for Second-Quarter 2026 Earnings Call
Investors are looking toward North Chicago as AbbVie prepares to disclose its financial performance for the second quarter of 2026. The pharmaceutical giant scheduled the release of its latest results for the morning of July 31, ahead of the opening bell for the markets.
AbbVie continues to maintain its focus on therapeutic areas including immunology, neuroscience, and oncology, alongside its Allergan Aesthetics portfolio. The upcoming session serves as a primary update on the company’s progress in delivering medical solutions across these sectors.
Comments (0)
No comments yet. Be the first!